GeneCast Biotechnology Funding: $246M Raised, Series E
GeneCast Biotechnology is based in Taizhou, China. It has raised $246M in total funding. Latest round: Series E.
GeneCast Biotechnology funding overview
GeneCast Biotechnology is based in Taizhou, China. GeneCast Biotechnology has raised $246M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in October 2020. The round record for GeneCast Biotechnology runs through 2020; nothing later has been disclosed. Investors on record include Matrix Partners China, Cowin Capital, CICC Capital. 3 distinct backers are named across the disclosed rounds.
GeneCast Biotechnology at a glance
Total raised
$246M
Latest round
Series E
Latest round date
October 2020
Headquarters
Taizhou, China
Notable investors
Matrix Partners China, Cowin Capital, CICC Capital
Frequently asked about GeneCast Biotechnology funding
How much has GeneCast Biotechnology raised?
GeneCast Biotechnology has raised $246M in total disclosed funding across the rounds on record.
Who has invested in GeneCast Biotechnology?
Matrix Partners China, Cowin Capital, CICC Capital are named among the investors backing GeneCast Biotechnology.
What was the latest GeneCast Biotechnology funding round?
The most recent disclosed round is a Series E, announced in October 2020.
Where is GeneCast Biotechnology based?
GeneCast Biotechnology is based in Taizhou, China.
When did GeneCast Biotechnology last raise?
The last disclosed GeneCast Biotechnology round closed in October 2020 at Series E.
We update the GeneCast Biotechnology record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Taizhou and their backers are listed below.
